| Primary |
| Helicobacter Infection |
57.6% |
| Gastric Ulcer |
6.8% |
| Duodenal Ulcer |
3.4% |
| Gastritis |
3.4% |
| Iron Deficiency |
3.4% |
| Arthritis |
1.7% |
| Barrett's Oesophagus |
1.7% |
| Gastritis Bacterial |
1.7% |
| Gastroenteritis Viral |
1.7% |
| Gastrointestinal Bacterial Infection |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Helicobacter Pylori Identification Test |
1.7% |
| Helicobacter Pylori Identification Test Positive |
1.7% |
| Helicobacter Test Positive |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Infection |
1.7% |
| Peptic Ulcer |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Stomach Pain |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
|
| Respiratory Distress |
10.7% |
| Vision Blurred |
10.7% |
| Hyperhidrosis |
7.1% |
| Hypoglycaemic Coma |
7.1% |
| Renal Failure Acute |
7.1% |
| Speech Disorder |
7.1% |
| Abasia |
3.6% |
| Abdominal Discomfort |
3.6% |
| Abdominal Pain Upper |
3.6% |
| Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis |
3.6% |
| Aspartate Aminotransferase Increased |
3.6% |
| Cardiac Failure |
3.6% |
| Colitis Ischaemic |
3.6% |
| Deformity |
3.6% |
| Diarrhoea |
3.6% |
| Drug Eruption |
3.6% |
| Dyspnoea |
3.6% |
| Erythema Multiforme |
3.6% |
| Fall |
3.6% |
| Glomerulosclerosis |
3.6% |
|
| Secondary |
| Helicobacter Infection |
30.1% |
| Product Used For Unknown Indication |
12.3% |
| Blood Cholesterol Increased |
6.8% |
| Dyspepsia |
5.5% |
| Hypertension |
5.5% |
| Prophylaxis |
5.5% |
| Hypothyroidism |
4.1% |
| Blood Triglycerides Increased |
2.7% |
| Cardiovascular Event Prophylaxis |
2.7% |
| Depression |
2.7% |
| Diabetes Mellitus |
2.7% |
| Flushing |
2.7% |
| Gastric Ulcer Haemorrhage |
2.7% |
| Oral Contraception |
2.7% |
| Peptic Ulcer |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Affective Disorder |
1.4% |
| Arthritis |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Crohn's Disease |
1.4% |
|
| Erythema Multiforme |
13.3% |
| Peptic Ulcer |
13.3% |
| Alanine Aminotransferase Increased |
6.7% |
| Arthralgia |
6.7% |
| Cholecystitis Chronic |
6.7% |
| Diarrhoea |
6.7% |
| Extranodal Marginal Zone B-cell Lymphoma (Malt Type) |
6.7% |
| Fatigue |
6.7% |
| Loss Of Consciousness |
6.7% |
| Myopathy |
6.7% |
| Neuropathy Peripheral |
6.7% |
| Tongue Discolouration |
6.7% |
| Vomiting |
6.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.0% |
| Depression |
19.4% |
| Contraception |
10.3% |
| Drug Use For Unknown Indication |
4.8% |
| Hypertension |
4.3% |
| Premenstrual Syndrome |
3.5% |
| Helicobacter Gastritis |
3.3% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Menopause |
3.0% |
| Acne |
2.5% |
| Blood Cholesterol Increased |
2.5% |
| Anticoagulant Therapy |
2.3% |
| Pain |
2.3% |
| Helicobacter Infection |
1.8% |
| Hormone Replacement Therapy |
1.8% |
| Menstrual Cycle Management |
1.8% |
| Oral Contraception |
1.8% |
| Osteoarthritis |
1.8% |
| Insomnia |
1.5% |
| Non-small Cell Lung Cancer |
1.5% |
|
| Ventricular Septal Defect |
13.7% |
| Vomiting |
12.3% |
| Weight Increased |
9.6% |
| Nausea |
6.8% |
| Vulvovaginal Candidiasis |
6.8% |
| Wound |
6.8% |
| Cholecystitis Chronic |
4.1% |
| Cholelithiasis |
4.1% |
| Gallbladder Disorder |
4.1% |
| Pain |
4.1% |
| Aphagia |
2.7% |
| Biliary Dyskinesia |
2.7% |
| Choking |
2.7% |
| Decreased Appetite |
2.7% |
| Deep Vein Thrombosis |
2.7% |
| Economic Problem |
2.7% |
| Injury |
2.7% |
| Myocardial Infarction |
2.7% |
| Palpitations |
2.7% |
| Pollakiuria |
2.7% |
|
| Interacting |
| Gastric Infection |
50.0% |
| Smoking Cessation Therapy |
50.0% |
|
|
